The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
The Neuroendocrine Tumor Research Foundation directs your individual donations to breakthrough scientific research. Since 2005, we have funded $36 million in research projects. The Neuroendocrine Research Foundation is a 501(c)(3) organization, so all donations are fully tax-deductible to the extent allowed by law. We are grateful to you for your generosity.
Home » For Patients » Living with NETs » Coronavirus Disease (COVID-19) Outbreak » Mental Health and Well-being
Before a global pandemic turned people’s lives upside down, managing a NET diagnosis was stressful. Now, the strain of juggling delayed or canceled appointments, isolation, and even worrying about exposure to COVID-19 is adding uncertainty, anxiety, and grief to people’s lives.
In this video interview, oncology social worker Kalen Fletcher, MSW, LICSW, MPH from Beth Israel Deaconess Medical Center in Boston joins Elyse Gellerman, NETRF Chief Executive Officer, to talk about managing mental health during COVID-19.
Watch as Kalen and Elyse talk about dealing with changes, treatment delays, and disruptions to cancer care. You’ll learn how to combat feelings of isolation, anxiety, or sadness with effective coping strategies.
Netrf.org terms and conditions: This information is not intended as and shall not be relied upon as medical advice. The Neuroendocrine Tumor Research Foundation encourages all users to discuss any information found here with their oncologist, physician, and/or appropriate qualified health professional.
The COVID-19 outbreak is rapidly changing. Aspects of the content may have changed since it was published. To stay abreast of the situation, follow these trusted resources for the latest information: